XOMA - 32 Year Stock Price History | XOMA

Historical daily share price chart and data for XOMA since 1989 adjusted for splits. The latest closing stock price for XOMA as of September 27, 2021 is 25.35.
  • The all-time high XOMA stock closing price was 9595.20 on March 05, 1991.
  • The XOMA 52-week high stock price is 46.32, which is 82.7% above the current share price.
  • The XOMA 52-week low stock price is 18.51, which is 27% below the current share price.
  • The average XOMA stock price for the last 52 weeks is 32.92.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
XOMA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 33.9611 39.8200 43.9900 23.5100 25.3500 -42.56%
2020 23.4892 27.6800 45.6100 15.1100 44.1300 61.65%
2019 17.3011 13.2700 28.6600 11.8300 27.3000 115.81%
2018 21.2280 35.9200 35.9200 11.2700 12.6500 -64.47%
2017 12.5470 4.9700 36.7900 4.0300 35.6000 743.60%
2016 12.4726 26.8000 26.8000 4.2200 4.2200 -84.14%
2015 50.2669 71.0000 94.4000 14.4120 26.6000 -62.95%
2014 100.2528 138.4000 188.8000 68.6000 71.8000 -46.66%
2013 81.3167 51.8000 146.0000 50.2000 134.6000 180.42%
2012 53.9870 25.0000 79.0000 24.8000 48.0000 108.70%
2011 57.1240 106.0000 146.1000 22.0000 23.0000 -77.58%
2010 118.3450 209.8651 238.0810 45.6000 102.6000 -51.03%
2009 218.7597 200.8996 353.8231 113.9430 209.5352 12.71%
2008 601.4329 959.5202 959.5202 179.9100 185.9070 -81.71%
2007 933.1275 647.6762 1280.3598 602.6987 1016.4918 54.09%
2006 557.6432 500.7496 731.6342 476.7616 659.6702 37.50%
2005 481.9745 767.6162 767.6162 296.8516 479.7601 -38.22%
2004 1180.0909 2008.9955 2290.8546 587.7061 776.6117 -60.76%
2003 1811.8744 1202.3988 2944.5277 875.5622 1979.0105 56.03%
2002 1762.7817 2800.5997 3523.2384 929.2354 1268.3658 -57.06%
2001 3003.2173 2623.6882 5115.4423 1668.0660 2953.5232 1.03%
2000 2421.7213 890.2549 4536.7316 843.4783 2923.5382 225.00%
1999 1224.6198 1011.9940 2352.0240 618.5907 899.5502 -5.90%
1998 1216.8416 1705.5472 1836.5817 590.4048 955.9220 -42.69%
1997 1791.4643 1508.5457 2417.6912 1180.8096 1668.0660 8.44%
1996 1526.9343 1199.4003 2398.8006 937.0315 1538.2309 46.57%
1995 733.9937 815.2924 1180.8096 393.7031 1049.4753 30.21%
1994 1065.6691 1649.1754 1799.1004 674.6627 805.9970 -48.80%
1993 2021.4422 2998.5007 2998.5007 1499.2504 1574.2129 -45.45%
1992 4557.9159 6110.9445 7346.3268 2698.6507 2886.0570 -54.17%
1991 6760.4103 5997.0015 9595.2024 4272.8636 6296.8516 2.44%
1990 6053.3330 7085.4573 7796.1019 4647.6762 6146.9265 -5.75%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.287B $0.029B
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1? with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29